Overview Reversal of Ventricular Remodeling With Toprol-XL Status: Completed Trial end date: 2003-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease. Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: Metoprolol